Prof. Dr. Ahmet Tutar is a faculty member in the Department of Chemistry at Sakarya University . His academic activities include teaching courses such as Organic Chemistry I/II , Organic Synthesis Design , and Stereochemistry , alongside supervising numerous master's theses in organic synthesis and humic substance applications. Research Interests: Focus on bromination reactions , BODIPY dye synthesis , humic/fulvic acid characterization , computational chemistry , and pharmaceutical applications of organic compounds. Key Article Trends: Recent publications emphasize photobromination methods , metal-organic frameworks , and biological activity of brominated derivatives , with keywords spanning organic synthesis , biochemistry , and environmental chemistry . Thesis Supervision: Guided 35+ master's theses (2007-2013) on topics like synthesis of brominated indan derivatives , humic acid extraction , and photobromination of terpenes .
David John Procter is a Professor of Organic Chemistry and Head of the Department of Chemistry at the University of Manchester. His career includes academic roles at the University of Glasgow (Lecturer, Senior Lecturer) and a Readership at the University of Manchester, where he became a Professor in 2008. His research focuses on developing new synthetic methods, catalysis, and materials chemistry, with applications in drug discovery, biocatalysis, and organic electronics. Education: BSc Chemistry (University of Leeds, 1992), PhD (1995, supervised by Prof. Christopher Rayner). Postdoctoral work: Florida State University (Prof. Robert Holton, Taxol analog synthesis). Research interests include samarium diiodide-mediated reactions, metal-free coupling processes, and sustainable synthesis methods. He leads projects funded by EPSRC, Industry (30 grants), and international collaborations. Awards include the EPSRC Established Career Fellowship (2015–2020), Bader Prize (2014), and Young Heterocyclic Chemist Award (2015). Key contributions: Total synthesis of natural products (e.g., pleuromutilin), development of copper-catalyzed multicomponent couplings, and innovative methods for organic materials. His work aligns with UN Sustainable Development Goals related to affordable and clean energy and responsible consumption. Collaborations span academic and industrial partnerships in chemistry, physics, and biology. He supervises 60+ students and contributes to the Organic Materials Innovation Centre (OMIC). His group’s research is detailed at proctergroupresearch.com .
Prof. Paul Stupple is a Professor of Medicinal Chemistry at Monash University, Australia, with over 20 years' experience in pharmaceutical industry and academia. He holds leadership roles at Canthera Discovery and manages the Australian Translational Medicinal Chemistry Facility. His expertise lies in small molecule drug discovery, particularly targeting cancer therapies and epigenetic regulators. Affiliations: Monash University, Faculty of Pharmacy and Pharmaceutical Sciences Canthera Discovery (Director, Medicinal Chemistry) Education: BA and DPhil in Chemistry from the University of Oxford (1992–1999). Early career at Pfizer as a medicinal chemistry leader, delivering 6 clinical candidates. Key contributions include: Licensing deals with Merck (2016) and Pfizer (2018) for preclinical projects Leading the Cancer Therapeutics CRC's medicinal chemistry program Research Interests: Small molecule drug discovery focused on histone acetyltransferase inhibitors, cancer therapeutics, and epigenetic modulation. Notable projects include development of KAT6A/B inhibitors for ER+ breast cancer and STING agonists for immunotherapy. Grants/Projects: Principal Investigator for major initiatives like MedChem Australia (2023–2028) and drug target identification platforms. Collaborates widely with institutions like WEHI and University of Sydney. Over 28 peer-reviewed publications spanning 1997–2025. Labs/Teams: Oversees the Australian Translational Medicinal Chemistry Facility, a key resource for drug discovery in Australia.
Dr. Monica E. McCallum is an Assistant Professor of Chemistry in the Department of Chemistry at the University of Pennsylvania’s School of Arts & Sciences. Her research focuses on understanding the biochemical origins of natural products and their roles in microbial communication. She leads the McCallum Lab, which employs interdisciplinary approaches combining organic synthesis, biochemistry, microbiology, and microscopy to study microbial natural products in their native contexts. Education: 2016 – Postdoctoral Fellow at Harvard University under Prof. Emily P. Balskus 2016 – PhD in Organic Chemistry from Baylor University 2013 – PhD Candidate at Colorado State University 2011 – B.S. in Chemistry from University of California, Irvine Research Interests: Dr. McCallum’s work bridges organic synthesis and microbiology to decode microbial metabolite functions. Key themes include: Synthesizing complex natural products and their biosynthetic precursors Discovering novel enzyme-catalyzed reactions Unraveling microbial communication mechanisms via natural products Investigating environmental microbial community dynamics Lab & Collaborations: The McCallum Lab emphasizes interdisciplinary collaboration, integrating techniques from organic chemistry, molecular biology, and microscopy to study natural products in situ. Current projects focus on diazeniumdiolate biosynthesis pathways and enzymatic detoxification of marine toxins.
Prof. Dr. Philipp Heretsch is a Professor and Executive Director at the Institute of Organic Chemistry, Faculty of Natural Sciences, Leibniz University Hannover. He leads the Natural Product Synthesis research group and holds key roles in academic governance, including Deputy Coordinator for Exchange Programmes and representation on various examination and curriculum boards. Research Interests: His research focuses on the synthesis of complex natural products, particularly terpenes and alkaloids, using biosynthesis-inspired strategies. He develops novel carbon–carbon bond manipulation techniques and rearrangement cascades. A significant emphasis is placed on the biological activity of synthesized compounds. He also pioneers the development of continuous flow reactor systems for the selective transformation of sensitive and short-lived chemical species. Publication Trends: His recent publications (2020–2025) demonstrate a strong focus on biogenesis-inspired total synthesis of highly complex natural products (e.g., canataxpropellane, swinhoeisterol), the application of radical-polar crossover and rearrangement strategies, and the innovative use of flow chemistry for scalable and efficient synthesis of both natural products and functional molecules like odorants and ferrocenyl compounds. Scientific Awards: ADUC Prize of the GDCh (2018) DECHEMA Young Scientist Prize for Natural Product Research (2020) ORCHEM Prize for Young Scientists of the Liebig Association for Organic Chemistry of the GDCh Advising and Grants: While specific students are not listed, he leads an active research group. His work is supported by significant external funding, including an ERC Consolidator Grant for the project "RadCrossSyn" and support from the DFG Heisenberg Program, which facilitated his move to Leibniz University Hannover in 2021. Labs and Teams: He heads the Natural Product Synthesis research group at the Institute of Organic Chemistry, Leibniz University Hannover. His research group, often referred to as the "Heretsch group," is dedicated to developing novel synthetic methodologies and applying them to the synthesis of biologically relevant natural products.
Stéphane BAUDRON is a CNRS Research Director at the Laboratory for the Synthesis and Functions of Molecular Architectures within the Faculty of Chemistry at the University of Strasbourg. His research spans multiple areas of molecular materials chemistry, with particular expertise in coordination polymers, metal-organic frameworks, and supramolecular architectures. Dr. BAUDRON's educational background includes undergraduate studies at the National School of Chemistry of Paris (1998), a Ph.D. from the University of Angers under Dr. Patrick Batail (2002), and postdoctoral research at the University of California Berkeley with Prof. Jeffrey R. Long (2002-2004). He joined CNRS as a researcher in 2004, received his Habilitation from the University of Strasbourg in 2009, and was promoted to CNRS Research Director in 2019. His primary research interests focus on dipyrrin-based complexes and assemblies for luminescent materials and heterometallic frameworks, conducting coordination polymers using redox-active ligands, and the application of deep eutectic solvents for sustainable synthesis of porous materials. His work bridges fundamental coordination chemistry with practical applications in materials science. Analysis of his recent publications reveals a strong trend toward green chemistry approaches for synthesizing metal-organic frameworks, with increasing focus on deep eutectic solvents as environmentally friendly alternatives to traditional solvents. His research spans both fundamental coordination chemistry and applied materials science, with particular emphasis on structure-property relationships in crystalline materials. Lavoisier fellowship (French Ministry of Foreign Affairs) JSPS short-term invitation fellowship at Kyoto University USIAS fellowship ANR DEEPCatCOF project (Principal Investigator) Dr. BAUDRON has successfully mentored numerous graduate students who have gone on to careers in both industry and academia, including positions at Michelin, BASF, and various universities. His current research is supported by multiple grants, including the ANR DEEPCatCOF project focused on deep eutectic solvents for catalytic metal-organic frameworks. His laboratory maintains strong international collaborations with research groups in Japan, Portugal, and other European institutions. Based at the University of Strasbourg's Institute Le Bel, Dr. BAUDRON leads a research team within the Laboratory for the Synthesis and Functions of Molecular Architectures, which is part of the larger Faculty of Chemistry structure. His group actively collaborates with other laboratories within the chemistry faculty, particularly those working on spectroscopy, mass spectrometry, and molecular modeling.
Prof. Dr. Armido Studer is a Full Professor of Organic Chemistry at the Institute of Organic Chemistry, Faculty of Mathematics and Natural Sciences, University of Münster (WWU Münster), Germany. He has been serving as a Full Professor (W3) since November 2009, following his appointment as a Full Professor (C4) in 2004. Studer also serves as the Spokesman of the International Research Training Group IRTG 2678 'Functional π-Systems: Activation, Interaction and Application (pi-Sys)' since 2021 and previously led the Collaborative Research Center SFB 858 'Synergetic Effects in Chemistry - From Additivity towards Cooperativity' from 2010 to 2021. Studer received his education at ETH Zürich, where he completed his diploma thesis and doctoral studies under Prof. Dr. D. Seebach. He conducted postdoctoral research at the University of Pittsburgh with Prof. Dr. D. P. Curran before returning to ETH Zürich for his habilitation. His academic career includes positions as Associate Professor at Philipps-Universität Marburg (2000-2004) and subsequent professorships at WWU Münster. Professor Studer's research focuses on radical chemistry, particularly in the development of new synthetic methods using radical intermediates. His work spans free radical chemistry, electron catalysis, and the application of nitroxides in organic synthesis. Recent research directions include 'Radical Chemistry with the Hydrogen Atom Through Water Activation (H-dot)' and 'The Electron as a Catalyst: e-cat', both funded by ERC Advanced Grants. His group has made significant contributions to C-H functionalization, skeletal editing of heterocycles, and cooperative catalysis involving photoredox and N-heterocyclic carbene systems. The research has applications in pharmaceutical chemistry, materials science, and sustainable chemical synthesis. Studer's publication record shows a strong focus on heterocyclic chemistry, radical reactions, and catalytic methodologies. His recent work demonstrates expertise in meta-selective functionalization of heteroarenes, skeletal editing techniques, and the development of novel radical cascade reactions. The group has published extensively in high-impact journals including Nature, Science, JACS, and Angewandte Chemie. Adolf-von-Baeyer-Denkmünze (2025) Arthur C. Cope Late Career Scholars Award of the American Chemical Society (2024) ERC Advanced Grants (2024, 2016) Multiple Highly Cited Researcher designations (2017-2022) Elected member of multiple academies (European Academy of Sciences, Academia Europaea, German National Academy of Sciences Leopoldina) Pedler Award of the Royal Society of Chemistry (2019) Professor Studer has mentored over 100 PhD students and postdoctoral researchers who have gone on to successful careers in academia and industry worldwide. His research is supported by significant grants including multiple ERC Advanced Grants and funding from the German Research Council (DFG) for collaborative research centers. The Studer Group maintains numerous international collaborations, particularly with institutions in Japan, China, and the United States, reflecting his global impact in organic chemistry. The Studer Group operates state-of-the-art laboratories at the University of Münster, equipped for advanced organic synthesis, photochemistry, and materials characterization. The group is known for its collaborative culture and has been featured in numerous group photos documenting its evolution since the early 2000s, first at Philipps-Universität Marburg and then at WWU Münster.
Raphael Franzini serves as Associate Professor of Medicinal Chemistry at the University of Utah, actively contributing to the Biological Chemistry PhD Program. His research pioneers innovative chemical approaches for therapeutic development, with dual focus on DNA-encoded library technologies and bioorthogonal drug delivery systems. His educational foundation includes an M.S. from the Swiss Federal Institute of Technology (Lausanne) and a Ph.D. from Stanford University. This training underpins his group's multidisciplinary methodology combining organic synthesis, bioconjugation, computational modeling, and advanced imaging techniques. Dr. Franzini's research program centers on two transformative areas: First, advancing DNA-encoded library screening through computational integration to identify leads for challenging targets like Tankyrase and Sirtuin 6, with recent work addressing false negatives in machine learning prediction. Second, developing novel bioorthogonal release chemistry using isonitrile-tetrazine reactions for spatiotemporally controlled drug activation, validated in zebrafish models. His group emphasizes both technological innovation and therapeutic translation, with chemistry designed to minimize off-target effects in solid tumors. Analysis of his 15 most recent publications reveals escalating integration of computational methods with experimental library screening, alongside refinement of bioorthogonal release kinetics. The work spans chemical biology, medicinal chemistry, and pharmaceutical sciences, with growing emphasis on machine learning for library data interpretation and in vivo validation of drug-release systems. Dr. Franzini maintains an active research laboratory that provides comprehensive training in cutting-edge drug discovery methodologies. His group culture prioritizes both scientific innovation and researcher development, with projects spanning from fundamental reaction kinetics to therapeutic applications. The lab's infrastructure supports organic synthesis, molecular imaging, and computational analysis for advancing precision therapeutics.
Scott E. Denmark is the Reynold C. Fuson Professor of Chemistry at the University of Illinois, Department of Chemistry, within the College of Liberal Arts & Sciences. He earned his S.B. from MIT (1975) and D.Sc. Tech. from ETH-Zürich (1980) under Albert Eschenmoser. His research focuses on synthetic organic chemistry, organoelement systems (Si, P, Sn, S, Li), palladium catalysis, and chemoinformatics. He has pioneered methods in asymmetric catalysis, total synthesis of natural products, and tandem cycloaddition reactions. Denmark chairs editorial boards for top journals and leads the Denmark Group, mentoring over 100 students. Awards include the Paracelsus Prize (2020), Noyori Prize (2019), and membership in the National Academy of Sciences (2018). Education: S.B., Massachusetts Institute of Technology, 1975 D.Sc. Tech., ETH-Zürich, 1980 (Advisor: Albert Eschenmoser) Research Interests: Design of new organic reactions and catalysts Structure-reactivity relationships in organoelement systems Total synthesis of alkaloids, polyenes, and glycosides Machine learning for catalyst optimization Asymmetric phase transfer catalysis Green chemistry using water-based systems Recent Research Trends: Recent work emphasizes indium-catalyzed allylations of carbohydrates (Nature, 2025) and chemoinformatics-driven catalyst design. Collaborations with MIT and industry (e.g., Pfizer, Amgen) highlight applied impact. Awards: Paracelsus Prize (2020) Ryoji Noyori Prize (2019) Member, National Academy of Sciences (2018) Member, American Academy of Arts and Sciences (2017) Advising & Grants: Mentored 40+ PhD students and 60+ postdocs. Active in funding initiatives for chemoinformatics and sustainable catalysis. Recent grants include Pines Fellowship (2025) for student Matthew Albritton. Labs/Teams: Leads the Denmark Group at UIUC, known for interdisciplinary projects merging organic synthesis with computational methods. Collaborates globally, including with ETH-Zürich and Hiroshima University.
Kathrin Lang is a Full Professor at the Department of Chemistry and Applied Biosciences, ETH Zurich, and Head of the Organic Chemistry Laboratory. Her research focuses on chemical biology, particularly the development of tools for genetic code expansion to incorporate non-canonical amino acids into proteins and advance bioorthogonal chemistries for studying biological processes. Keywords: Genetic Code Expansion, Bioorthogonal Chemistry, Protein Engineering, Ubiquitylation Networks, Post-Translational Modifications. Lang’s work emphasizes proximity-triggered crosslinking reactions, bioorthogonal labeling, and in vivo chemistries to address challenges in protein interaction mapping and structural elucidation. Her group’s recent publications highlight methodologies for dual protein labeling, deciphering ubiquitin code, and enhancing cycloaddition reactivity. Current projects include exploring cyclopropene-fused dibenzocyclooctynes for improved labeling and investigating methylated lysine as a conformational regulator in Hsp90. Funding sources include the ERC (Ubl-tool), DFG (SFB1035, SPP1926), and ETH Zurich. She contributes to education through courses like Genetic Code Expansion for Studying Posttranslational Modifications and Chemical Biology and Synthetic Biochemistry . Collaborative efforts span structural biology, microbiology, and synthetic biochemistry, with applications in ubiquitin research and cellular imaging.
Robert R. Knowles is the Henry W. Putnam Professor of Chemistry at Princeton University , where he leads a research group focused on proton-coupled electron transfer (PCET) and light-driven catalytic transformations . His work bridges organic synthesis , photoredox chemistry , and asymmetric catalysis , with applications in pharmaceutical synthesis, polymer recycling, and sustainable chemistry. Research Highlights Pioneering PCET mechanisms for homolytic bond activation Developing enantioselective radical transformations Innovating contrathermodynamic photochemical reactions Advancing light-driven chemical recycling of thermosets Recent trends in publications include asymmetric catalysis with radical intermediates, photoredox-driven C–H functionalization, and contrathermodynamic isomerization reactions. His group frequently employs visible light and chiral hydrogen-bonding catalysts to achieve unprecedented reactivity. Scientific Awards : E. J. Corey Award (American Chemical Society) 2023 Arthur C. Cope Scholar Award (American Chemical Society) 2018 Mitsui Catalysis Science Award of Encouragement 2018 Novartis Early Career Award in Organic Chemistry 2017 Camille Dreyfus Teacher-Scholar Award 2017 ... (8 more awards) Contact: rknowles@princeton.edu
Kay Severin is a full professor at the Laboratory of Supramolecular Chemistry (LCS) within École Polytechnique Fédérale de Lausanne (EPFL) , Switzerland. His research focuses on the design and reactivity of metal-ligand assemblies, including coordination cages, metalloligands, and supramolecular receptors. He has pioneered the use of metalloligands for constructing heterometallic architectures and developed systems for anion extraction and stimuli-responsive hydrogels. Key funder: Swiss National Science Foundation (FNS) Collaborative work with Rosario Scopelliti and Farzaneh Fadaei Tirani Research Interests: Severin's work spans supramolecular chemistry, organometallic synthesis, and functional materials. Recent projects include: Dynamic palladium-based hydrogels with anion-responsive crosslinks Gold(I)-driven nano-onion structures via π-stacking Triazene-derived ligands for Sandmeyer-type reactions Metalloligand assembly of Fe/Pd/Au heterotrimetallic cages Publication Trends: Over 300 publications since 1994, with recent emphasis on: Coordination-driven self-assembly (2024: 6 articles) Triazene and diazoolefin reactivity (2025: 4 articles) Metal-ligand interactions in nanogels and vesicles (2024-2025: 3 articles) Environmental applications in anion extraction (2025: 1 article)
Dale L. Boger is a Professor of Chemistry at The Scripps Research Institute (TSRI), where he leads the Boger Group specializing in synthetic organic and medicinal chemistry. His academic roles include serving as co-Chair (2017-2018) and Chairman (2013-2017) of the Chemistry Department. Boger earned his B.S. from the University of Kansas (1975) and Ph.D. from Harvard University (1980). His research focuses on total synthesis of natural products, development of synthetic methodologies, and antibiotic design, particularly addressing antibiotic resistance via glycopeptide analogs like vancomycin. Key honors include the Paul Janssen Prize (2002), RSC Robert Robinson Award (2017), and election to the National Academy of Sciences (2014). His work spans collaborations in bioorganic chemistry, molecular modeling, and drug design. The Boger Group’s lab includes numerous students and postdocs, advancing projects such as maxamycins and guanidine-modified vancomycins. Funding includes NIH grants and industry partnerships, highlighting his contributions to both academic and applied research. Research highlights include groundbreaking studies on vancomycin analogs with dual mechanisms of action to combat resistance, as well as contributions to TLR agonists and neurovascular drug delivery. His legacy includes over 300 publications and impactful patents in antibiotic design and synthetic organic chemistry.
Prof. Dr. Helma Wennemers serves as a Full Professor at ETH Zurich's Department of Chemistry and Applied Biosciences, leading the Laboratory for Organic Chemistry. Her research group operates from HCI H 313 at Vladimir Prelog Way 1-5/10 in Zurich, Switzerland, with active teaching responsibilities including Organic Chemistry I and Chemical Biology - Peptides for the Fall 2025 semester. Her research program centers on the intersection of organic chemistry and chemical biology , with particular emphasis on collagen triple helix engineering , peptide-catalyzed asymmetric synthesis , and development of chemical tools for tissue remodeling diagnostics . Key focus areas include designing hyperstable collagen heterotrimers for fibrosis monitoring, creating fluorophore-based probes for collagen cross-linking visualization, and pioneering organocatalytic methodologies for complex heterocycle synthesis. Her group actively explores how hydrophobic modifications and proline derivatives influence collagen stability and cellular uptake mechanisms. Analysis of her 15 most recent publications (2024-2025) reveals three dominant research trajectories: (1) collagen structural engineering for biomedical applications, (2) innovative peptide/organocatalysis enabling stereoselective transformations, and (3) chemical probe development targeting tissue remodeling processes. These works consistently integrate synthetic chemistry with biological validation, demonstrating translational potential in fibrosis diagnostics and regenerative medicine. While specific grant details aren't provided in available sources, her research program clearly supports advanced laboratory infrastructure including peptide synthesis facilities and photochemical reaction systems like the ETHos photoreactor. Her group maintains strong industry and clinical collaborations evident in applications targeting liver cancer cells and prostate cancer diagnostics. The Laboratory for Organic Chemistry functions as an interdisciplinary hub where synthetic organic chemists collaborate with biologists to develop collagen-based diagnostic platforms and catalytic systems. Current projects focus on lysyl oxidase-responsive probes for real-time tissue monitoring and engineered peptide catalysts for sustainable chemical synthesis under environmentally relevant conditions.
Barry Martin Trost is the Tamaki Professor of Humanities and Sciences in the Department of Chemistry at Stanford University. Previously, he served as a professor at the University of Wisconsin, where he held several distinguished positions including Evan P. and Marion Helfaer Professor of Chemistry and Vilas Research Professor of Chemistry. His academic career spans over five decades with significant contributions to the field of organic chemistry. Dr. Trost received his B.A. from the University of Pennsylvania in 1962, where he was awarded the Philadelphia Board of Education Scholarship (1959-62). He earned his Ph.D. from the Massachusetts Institute of Technology in 1965 under the supervision of H.O. House, with a dissertation titled "The Structure and Reactivity of Enolate Anions." During his graduate studies, he was a National Science Foundation Predoctoral Fellow (1963-65). Professor Trost's research focuses on synthetic organic chemistry with particular emphasis on transition metal catalysis, asymmetric synthesis, and green chemistry principles. His work has pioneered numerous catalytic methods, especially in palladium chemistry, with a strong focus on atom economy - a concept he developed that has become fundamental to sustainable chemistry practices. His laboratory has made significant contributions to the development of catalytic asymmetric allylic alkylation and other carbon-carbon bond forming reactions that enable the efficient synthesis of complex molecules. An analysis of his recent publications reveals a continued emphasis on innovative catalytic methodologies. His work prominently features palladium-catalyzed asymmetric reactions, particularly allylic alkylations and cycloadditions, which have become powerful tools for constructing challenging stereocenters. He has also expanded into vanadium catalysis and developed the Zn-ProPhenol catalyst system for various asymmetric transformations. His research consistently bridges fundamental methodology development with applications to natural product synthesis, demonstrating the practical utility of his catalytic systems. Professor Trost's exceptional contributions to chemistry have been recognized with numerous prestigious awards, including: Election to the National Academy of Sciences (1980) ACS Award in Pure Chemistry (1977) ACS Award for Creative Work in Synthetic Organic Chemistry (1981) Arthur C. Cope Award (2004) Presidential Green Chemistry Challenge Award (1998) Nobel Laureate Signature Award for Graduate Education (2002) As an educator and mentor, Professor Trost has supervised numerous graduate students and postdoctoral researchers who have gone on to successful careers in academia and industry. His group has been consistently supported by significant research grants, including a MERIT Award from the National Institutes of General Medical Sciences of NIH (1988), which provides long-term support for exceptionally productive investigators. He has served on numerous editorial boards, including as Associate Editor of the Journal of the American Chemical Society (1974-80) and Editor of CHEMTRACTS-Organic Chemistry (1993-present), helping to shape the direction of chemical research publication. The Trost Research Group at Stanford University continues to be a leading center for innovative research in synthetic organic chemistry. The group maintains strong collaborations with pharmaceutical and chemical industries, including longstanding relationships with Merck Research Laboratories and other major companies. Professor Trost's laboratory is particularly known for developing practical catalytic methods that emphasize efficiency, selectivity, and environmental sustainability - principles that have influenced an entire generation of synthetic chemists.
